These findings are supported also by Li H. et al. who proposed that elevated levels of endogenous FGF21 in obesity serve as a defense mechanism to protect against systemic insulin resistance [51]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.